Global Asthma Treatment Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03244150

Publication Date:

March 21, 2024

Pages:

114

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Asthma Treatment market size was valued at US$ 20630 million in 2023. With growing demand in downstream market, the Asthma Treatment is forecast to a readjusted size of US$ 23150 million by 2030 with a CAGR of 1.7% during review period.
The research report highlights the growth potential of the global Asthma Treatment market. Asthma Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Asthma Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Asthma Treatment market.
Asthma is an inflammatory disease of the airways to the lungs. It makes breathing difficult and can make some physical activities difficult or even impossible.
Treatments for asthma fall into three primary categories: breathing exercises, rescue or first aid treatments, and long-term asthma control medications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Asthma Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Asthma Treatment market. It may include historical data, market segmentation by Type (e.g., Breathing Exercises, Rescue/First Aid Treatments), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Asthma Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Asthma Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Asthma Treatment industry. This include advancements in Asthma Treatment technology, Asthma Treatment new entrants, Asthma Treatment new investment, and other innovations that are shaping the future of Asthma Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Asthma Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Asthma Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Asthma Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Asthma Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Asthma Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Asthma Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Asthma Treatment market.
Market Segmentation:
Asthma Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Breathing Exercises
Rescue/First Aid Treatments
Long-Term Asthma Control Medications
Monoclonal Antibody
Segmentation by application
Mild Intermittent
Mild Persistent
Moderate Persistent
Severe Persistent
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
GSK
Novartis
Boehringer Ingelheim
Merck & Co. Inc
Roche Holdings Ltd
Sunovion Pharmaceuticals Inc
Schering-Plough Corp
Sanofi
Theravance Inc

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Asthma Treatment Market Size 2019-2030
2.1.2 Asthma Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Asthma Treatment Segment by Type
2.2.1 Breathing Exercises
2.2.2 Rescue/First Aid Treatments
2.2.3 Long-Term Asthma Control Medications
2.2.4 Monoclonal Antibody
2.3 Asthma Treatment Market Size by Type
2.3.1 Asthma Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Asthma Treatment Market Size Market Share by Type (2019-2024)
2.4 Asthma Treatment Segment by Application
2.4.1 Mild Intermittent
2.4.2 Mild Persistent
2.4.3 Moderate Persistent
2.4.4 Severe Persistent
2.5 Asthma Treatment Market Size by Application
2.5.1 Asthma Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Asthma Treatment Market Size Market Share by Application (2019-2024)
3 Asthma Treatment Market Size by Player
3.1 Asthma Treatment Market Size Market Share by Players
3.1.1 Global Asthma Treatment Revenue by Players (2019-2024)
3.1.2 Global Asthma Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Asthma Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Asthma Treatment by Regions
4.1 Asthma Treatment Market Size by Regions (2019-2024)
4.2 Americas Asthma Treatment Market Size Growth (2019-2024)
4.3 APAC Asthma Treatment Market Size Growth (2019-2024)
4.4 Europe Asthma Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Asthma Treatment Market Size Growth (2019-2024)
5 Americas
5.1 Americas Asthma Treatment Market Size by Country (2019-2024)
5.2 Americas Asthma Treatment Market Size by Type (2019-2024)
5.3 Americas Asthma Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Asthma Treatment Market Size by Region (2019-2024)
6.2 APAC Asthma Treatment Market Size by Type (2019-2024)
6.3 APAC Asthma Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Asthma Treatment by Country (2019-2024)
7.2 Europe Asthma Treatment Market Size by Type (2019-2024)
7.3 Europe Asthma Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Asthma Treatment by Region (2019-2024)
8.2 Middle East & Africa Asthma Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Asthma Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Asthma Treatment Market Forecast
10.1 Global Asthma Treatment Forecast by Regions (2025-2030)
10.1.1 Global Asthma Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Asthma Treatment Forecast
10.1.3 APAC Asthma Treatment Forecast
10.1.4 Europe Asthma Treatment Forecast
10.1.5 Middle East & Africa Asthma Treatment Forecast
10.2 Americas Asthma Treatment Forecast by Country (2025-2030)
10.2.1 United States Asthma Treatment Market Forecast
10.2.2 Canada Asthma Treatment Market Forecast
10.2.3 Mexico Asthma Treatment Market Forecast
10.2.4 Brazil Asthma Treatment Market Forecast
10.3 APAC Asthma Treatment Forecast by Region (2025-2030)
10.3.1 China Asthma Treatment Market Forecast
10.3.2 Japan Asthma Treatment Market Forecast
10.3.3 Korea Asthma Treatment Market Forecast
10.3.4 Southeast Asia Asthma Treatment Market Forecast
10.3.5 India Asthma Treatment Market Forecast
10.3.6 Australia Asthma Treatment Market Forecast
10.4 Europe Asthma Treatment Forecast by Country (2025-2030)
10.4.1 Germany Asthma Treatment Market Forecast
10.4.2 France Asthma Treatment Market Forecast
10.4.3 UK Asthma Treatment Market Forecast
10.4.4 Italy Asthma Treatment Market Forecast
10.4.5 Russia Asthma Treatment Market Forecast
10.5 Middle East & Africa Asthma Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Asthma Treatment Market Forecast
10.5.2 South Africa Asthma Treatment Market Forecast
10.5.3 Israel Asthma Treatment Market Forecast
10.5.4 Turkey Asthma Treatment Market Forecast
10.5.5 GCC Countries Asthma Treatment Market Forecast
10.6 Global Asthma Treatment Forecast by Type (2025-2030)
10.7 Global Asthma Treatment Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Asthma Treatment Product Offered
11.1.3 AstraZeneca Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Asthma Treatment Product Offered
11.2.3 GSK Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Asthma Treatment Product Offered
11.3.3 Novartis Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Asthma Treatment Product Offered
11.4.3 Boehringer Ingelheim Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Boehringer Ingelheim Main Business Overview
11.4.5 Boehringer Ingelheim Latest Developments
11.5 Merck & Co. Inc
11.5.1 Merck & Co. Inc Company Information
11.5.2 Merck & Co. Inc Asthma Treatment Product Offered
11.5.3 Merck & Co. Inc Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck & Co. Inc Main Business Overview
11.5.5 Merck & Co. Inc Latest Developments
11.6 Roche Holdings Ltd
11.6.1 Roche Holdings Ltd Company Information
11.6.2 Roche Holdings Ltd Asthma Treatment Product Offered
11.6.3 Roche Holdings Ltd Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roche Holdings Ltd Main Business Overview
11.6.5 Roche Holdings Ltd Latest Developments
11.7 Sunovion Pharmaceuticals Inc
11.7.1 Sunovion Pharmaceuticals Inc Company Information
11.7.2 Sunovion Pharmaceuticals Inc Asthma Treatment Product Offered
11.7.3 Sunovion Pharmaceuticals Inc Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sunovion Pharmaceuticals Inc Main Business Overview
11.7.5 Sunovion Pharmaceuticals Inc Latest Developments
11.8 Schering-Plough Corp
11.8.1 Schering-Plough Corp Company Information
11.8.2 Schering-Plough Corp Asthma Treatment Product Offered
11.8.3 Schering-Plough Corp Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Schering-Plough Corp Main Business Overview
11.8.5 Schering-Plough Corp Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Asthma Treatment Product Offered
11.9.3 Sanofi Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 Theravance Inc
11.10.1 Theravance Inc Company Information
11.10.2 Theravance Inc Asthma Treatment Product Offered
11.10.3 Theravance Inc Asthma Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Theravance Inc Main Business Overview
11.10.5 Theravance Inc Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂